Here’s How the Pandemic Finally Ends

A vaccine by early 2021, a steady decline in cases by next fall and back to normal in a few years—11 top experts look into the future.

The microscopic bundles of RNA, wrapped in spiky proteins, latch on to human cells, hijack them, use them as factories to replicate, and then leave them for dead. It’s a biological blitzkrieg—an invasion so swift and unexpected that the germs are free to jump from host to host with little interference.

Fast forward to the future. Now, when the prickly enemies invade the lungs, they slip past the human cells, unable to take hold. They’re marked for destruction, soon to be surrounded and eliminated. Though some escape through the airways, they confront the same defenses in their next target—if, that is, they can get anywhere near the human cells. There are so few people left to infect that the germs have nowhere to replicate, nowhere to survive.

This is the end of the coronavirus pandemic. And this is how it could happen in the United States: By November 2021, most Americans have received two doses of a vaccine that, while not gloriously effective, fights the disease in more cases than not. Meanwhile, Americans continue to wear masks and avoid large gatherings, and the Covid-19 numbers drop steadily after a series of surges earlier in the year. Eventually, as more and more Americans develop immunity through exposure and vaccination, and as treatments become more effective, Covid-19 recedes into the swarm of ordinary illnesses Americans get every winter. Continue reading.

Why Are We Paying Moderna Twice For An Unproven Vaccine?

Moderna, a relatively new biotech firm, generally is seen as the U.S. frontrunner in developing a coronavirus vaccine.

It trails several Chinese companies.

Based in Cambridge, MA, Moderna should certainly get an award for milking the government.

It doesn’t matter if the vaccine works. Moderna already was paid twice over. Continue reading.

Five takeaways from Fauci’s testimony

The Hill logoWhen Anthony Fauci, the nation’s top infectious diseases doctor, testified before Congress a month ago, the U.S. had just set a record with 48,000 new coronavirus cases in a single day.

Now, the country is averaging nearly 65,000 new cases a day. Outbreaks in the South appear to be leveling off, but worrying trends are emerging in the Midwest. And the nationwide death toll recently topped 150,000, a once-unthinkable number that is only going to increase as the pandemic rages on.

But when Fauci and other top health officials testified before Congress on Friday, they struck a hopeful tone on the prospects for a COVID-19 vaccine, faster testing and getting the virus under control, so long as Americans are vigilant about wearing masks and avoiding crowds. Continue reading.

Coronavirus: A new type of vaccine using RNA could help defeat COVID-19

A century ago, on July 26, 1916, a viral disease swept through New York. Within 24 hours, new cases of polio increased by more than 68%. The outbreak killed more than 2,000 people in New York City alone. Across the United States, polio took the lives of about 6,000 people in 1916, leaving thousands more paralyzed.

Although scientists had already identified the polio virus, it took 50 more years to develop a vaccine. That vaccine eradicated polio in the U.S. in less than a decade. Vaccines are one of the most effective modern disease-fighting tools.

As of this writing, the fast-spreading COVID-19 has already infected almost half a million worldwide, and has killed over 22,000 patients. There is an urgent need for a vaccine to prevent it from infecting and killing millions more. But traditional vaccine development takes, on average, 16 years. Continue reading.